Anders Juul
Anders Juul publishes mostly in Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Molecular Biology, on topics such as Growth Hormone and Insulin-like Growth Factors, Sexual Differentiation and Disorders and Hypothalamic control of reproductive hormones.
- World rank
- #88,744 of 7,710,434 ranked researchers
- Rank in Denmark
- #517 of 43,819
- Works
- 1,009
- Citations
- 44k
- Citations per work
- 43.5
What does Anders Juul research?
Anders Juul's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences47447.0%
- Medicine47447.0%
- Everything else36636.3%
- Life Sciences16916.7%
- 1Endocrinology, Diabetes and Metabolism19% of their works
- 2Reproductive Medicine15% of their works
- 3Molecular Biology11% of their works
- 4Pediatrics, Perinatology and Child Health7% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Genetics6% of their works
Research topics
- Growth Hormone and Insulin-like Growth Factors
- Sexual Differentiation and Disorders
- Hypothalamic control of reproductive hormones
- Hormonal and reproductive studies
- Ovarian function and disorders
- Birth, Development, and Health
- Sperm and Testicular Function
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
Which keywords describe Anders Juul's research?
The keywords of their largest research topics: Neuroendocrine Control, Metabolic Syndrome, IGF-1, Insulin-like Growth Factors, Congenital Adrenal Hyperplasia, Steroid 21-Hydroxylase Deficiency, GPR54 Gene and Puberty.
- X Chromosome Inactivation
- Sperm DNA Fragmentation
- Fetal Programming
- Polycystic Ovary Syndrome
- Testosterone
- Puberty
- Steroid 21-Hydroxylase Deficiency
- Insulin-like Growth Factors
- Metabolic Syndrome
- Neuroendocrine Control
- IGF-1
- Congenital Adrenal Hyperplasia
- GPR54 Gene
- Hormone Therapy
- Ovarian Reserve
- Early-Life Conditions
- Oxidative Stress
- Sex Determination
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Neuroendocrine Control3862 topics
- Metabolic Syndrome3553 topics
- IGF-12331 topic
- Insulin-like Growth Factors2331 topic
- Congenital Adrenal Hyperplasia1991 topic
- Steroid 21-Hydroxylase Deficiency1991 topic
- GPR54 Gene1531 topic
- Puberty1531 topic
- Hormone Therapy1271 topic
- Testosterone1271 topic
- Ovarian Reserve1161 topic
- Polycystic Ovary Syndrome1161 topic
- Early-Life Conditions1121 topic
- Fetal Programming1121 topic
- Oxidative Stress1041 topic
- Sperm DNA Fragmentation1041 topic
- Sex Determination841 topic
- X Chromosome Inactivation841 topic
Where does Anders Juul work?
Anders Juul's main affiliation in the publication record is Rigshospitalet, Denmark.
How many publications and citations does Anders Juul have?
OpenAlex counts 1,009 works and 43,924 citations for Anders Juul, an h-index of 108, ranking #88,744 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Anders Juul
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anders Juul. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.